Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility of 5% Albumin Compared With Balanced Crystalloid, as Intravenous Fluid Resuscitation in Adult Patients With Sepsis, Presenting as an Emergency to Hospital: ABC Sepsis Trial

NCT04540094 is registered in ClinicalTrials.gov with University of Edinburgh as lead sponsor.

NCT NCT04540094
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04540094 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility of 5% Albumin Compared With Balanced Crystalloid, as Intravenous Fluid Resuscitation in Adult Patients With Sepsis, Presenting as an Emergency to Hospital: ABC Sepsis Trial
Lead sponsor
University of Edinburgh
Phase
Phase 3
Overall status
Completed
Start date
June 1, 2021
Completion date
April 30, 2023
Enrollment
300 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

sepsis